Therapies Archives - Oncology Central Oncology Central

Must read

5 Apr 2019 Lung
Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

5 Apr 2019 Hematologic
Hematological malignancy stem cell transplants: improving matches to reduce mortality
1 Apr 2019 Hematologic
AACR19: umbralisib trial results give support for use as a marginal zone lymphoma drug
31 Mar 2019 CAR-T therapy
AACR19: HER2 targeted CAR-T cell therapy shows promise in advanced sarcomas patients
31 Mar 2019 Lung
AACR19: mesothelin targeted CAR-T cell therapy – a possible treatment for solid tumors
13 Feb 2019 Lung
Defining aggressive or early progressing non-oncogene-addicted non-small-cell lung cancer: a separate disease entity?
12 Feb 2019 Brain and neurologic
Pembrolizumab could effectively treat recurrent glioblastoma, study suggests

Must watch

14 Sep 2018 Immuno-oncology
Seven challenges in immuno-oncology

Stay up to date

Upcoming event

Gastrointestinal Cancers Symposium

January 17, 2019 – January 19, 2019

CA, USA

View all

Upcoming event

International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer

February 9, 2019 – February 11, 2019

Kyoto, Japan

View all

Tweets

Oncology Central @OncologyCentral·

A recent study has found one in 10 cancer patients are denied drugs recommended by their doctor. Find out about the @ICR_London manifesto that is calling for action on cancer drug access https://t.co/aIUwvA38t7

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

Hematological malignancy stem cell transplants: improving matches to reduce mortality

AACR19: umbralisib trial results give support for use as a marginal zone lymphoma drug

AACR19: HER2 targeted CAR-T cell therapy shows promise in advanced sarcomas patients

AACR19: mesothelin targeted CAR-T cell therapy – a possible treatment for solid tumors

Defining aggressive or early progressing non-oncogene-addicted non-small-cell lung cancer: a separate disease entity?

Pembrolizumab could effectively treat recurrent glioblastoma, study suggests

Seven challenges in immuno-oncology

Palbociclib halts tumor growth in early breast cancer patients

Dual-action virus targets both cancer cells and associated fibroblasts

Promising Phase I trial for anti-HER2 antibody

NCRI 2018: Prostate cancer patients may prioritize the avoidance of side-effects over survival probability

What are the top 5 breast cancer advancements of 2018?

A dog’s 3D printed implant shows potential for cancer surgeries

Zika vaccine yields promising results for treating glioblastoma

New tool could predict how cancer will resist drugs before they are given to patients

Capturing Cancer: Oncology Central Photography Competition

Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

Comprehensive CAR T-cell therapy pediatric guidelines developed

ASCO18: Day 3 update

ASCO18: Abiraterone for advanced prostate cancer may be more effective for black men than white men

Cause of resistance to olaparib and other PARP inhibitors identified

Advancing treatment options for medullary thyroid cancer: an interview with Jonathan Wadsley

Characteristics and treatment patterns among US patients with hairy cell leukemia

Login

Therapies

Must read

Pembrolizumab for small-cell lung cancer: an interview with Hyun Cheol Chung

Hematological malignancy stem cell transplants: improving matches to reduce mortality

AACR19: umbralisib trial results give support for use as a marginal zone lymphoma drug

AACR19: HER2 targeted CAR-T cell therapy shows promise in advanced sarcomas patients

AACR19: mesothelin targeted CAR-T cell therapy – a possible treatment for solid tumors

Defining aggressive or early progressing non-oncogene-addicted non-small-cell lung cancer: a separate disease entity?

Pembrolizumab could effectively treat recurrent glioblastoma, study suggests

Must watch

Seven challenges in immuno-oncology

Palbociclib halts tumor growth in early breast cancer patients

Dual-action virus targets both cancer cells and associated fibroblasts

Promising Phase I trial for anti-HER2 antibody

NCRI 2018: Prostate cancer patients may prioritize the avoidance of side-effects over survival probability

What are the top 5 breast cancer advancements of 2018?

A dog’s 3D printed implant shows potential for cancer surgeries

Zika vaccine yields promising results for treating glioblastoma

New tool could predict how cancer will resist drugs before they are given to patients

Capturing Cancer: Oncology Central Photography Competition

Vistusertib with paclitaxel shows promise for ovarian and lung cancer in early trial

Comprehensive CAR T-cell therapy pediatric guidelines developed

ASCO18: Day 3 update

ASCO18: Abiraterone for advanced prostate cancer may be more effective for black men than white men

Cause of resistance to olaparib and other PARP inhibitors identified

Advancing treatment options for medullary thyroid cancer: an interview with Jonathan Wadsley

Characteristics and treatment patterns among US patients with hairy cell leukemia

Stay up to date

Oncology Central Newsletter